Member Info for Bella6532

Anyone quoting billion $ deals should also post the number of shares that were in issue and the SP prior to the deal...without this info you cannot compare apples with apples.

I've checked some of these big deals only to find the SP increase was relatively small.

Have you compared the Bid and Ask prices ...many of these No Fee sites don't give the 'best' prices...

The BIG Questions are...

Is the BOD in it for the long haul or would they simply take a good offer so they can move on to pastures new?

and how much are they will to hold out for?

I don't think you'll get anywhere near your SP wishlist on a T/O deal as we stand right now.

Deals and NASDAQ Listing will drive value but we need some big hitters in the Finance World like Healthcare Royalty to back Avacta and to negotiate the best T/O deal possible at the right time.

One point many have missed on here and I don't think has been discussed in detail...what about the number of people who refuse Chemo therapy because of the horrendous side effects and what about the many who just won't go and get checked because of the fear they might have cancer/side effects of treatment. I have/had several friends who refused chemo. One right now had radiotherapy (in itself horrendous) and is now on hormone tablets (again very uncomfortable side effects) and it's a fingers crossed as to whether it will work. For me, this is the group of people who will really benefit from our pipeline.

Mo oncologyst will ever talk 'cure'...remission is best you get. A friend who had breast cancer 25 years ago was clear until last year when it came back again aggressively. Yes cancer cells can be killed and all apparent traces might disappear but.....

Dox and other highly toxic chemo treatments often can't be administered long enough and at strong enough doses to a)kill all the cancer cells and/or b) beat ghe process of cell resistance. Remember the doses currently administered as stand alone chemo treatments (without PreCISION) are not necessaily the dose reaching the tumour(s) if it reaches at all.

This is why PreCISION is so exciting as are the next 2 pipeline products. It's not the warhead that's changed it's the fact it's carried to the tumour site by PreCISION that makes all the difference and now the regulators see this too...

PL75...one other thought..if the regulators are hsppy to lift the limit...I wonder how quickly they will give us approval once the efficacy data starts to come out.

Will they see it as a 'Must Have New Standard of Treatment'...

..is an improvement on..Oops!

'We can put almost any drug on Pre|CISION'

And it's PreCISION that's on trial here...Dox will do what Dox will do once in the tumour...

Each pipeline product is an improving on PreCISION.

ROLL UP! ROLL UP!! 'We can put almost any drug on Pre|CISION'..TELL US WHAT YOU WANT US TO PUT ON...WE WILL DO IT FOR £? LICENCING DEAL/ROYALTY DEAL....

BV you might find ghis interesting...cancers Dox can treat, dosage per cancers plus side effects and more...

https://www.ncbi.nlm.nih.gov/books/NBK459232/#:~:text=Doxorubicin%20may%20be%20used%20to,and%20small%20cell%20lung%20cancer.

'... current ADCs don’t significantly increase MTDs of their conjugated drugs across multiple oncology disease states despite broad diversity.'

https://www.sciencedirect.com/science/article/pii/S1535610822004457

mmm!!!

'with the potential to extend the progression free survival endpoint in trials.'...isn't this what we all want to see...especially the patients.

Now we seem to have a situation here where a few keyboard warriers, with no serious medical background know better than our in house scientists, our trial location medics and now regulators etc...couldn't make it up could you. If we have a Partner on the hook, they could have stipulated various key points need to be achieved prior to signing on the dotted line and todays news could well be such a key point.

They're now down to $89...

New online/mobile trading apps are having big impact on these sorts of shares...and will have on Avacta shares if there's a sniff of a big deal by a well known pharma backed up with press/media announcements.

This year their shares rose 400%...from around $30 to $150 per share and their market cap right now is around $23b.

Talking Billions for a T/O deal when you're already worth billions isn't the same as if you're only worth a few million...

And some wonder how shorters get their shares....sites like these and your broker sites...

'We lend shares from your portfolio to borrowers and receive interest in exchange. We split all interest equally with you. Share lending is fully automatic and will never cause delays when selling. You still get paid dividends in full.'

21-Jan-26 17:10:18 55.50 15,000 Unknown* 8,325 O

21-Jan-26 11:11:56 58.00 100,000 Unknown* 58.00k O

21-Jan-26 16:25:53 55.75 370 Buy* 206.28 O

Was the AVA6000 low starting dose more to do with the Dox element or PreCision or both...

Could the AVA6000 trial data allow for a higher starting dose since no MTD was attained at the very high dose levels...

DaProphet...'Quite sure they mentioned recently talks are ongoing on the commercial basis with numerous pharma companies'...

I'd be extremely worried if they weren't...

Sorry should have read

Would all these actions have taken place if a Partner/future Financier wasn't seriously calling the shots...you need to do this, you need to do that etc etc..

Product-based partnerships: partnering or out-licensing deals with large pharma/biotech companies that have clinical and/or commercial expertise in certain therapeutic areas, or geographies, could help accelerate development of either existing or new product candidates. We note that Avacta is actively seeking a deal for AVA6000, ahead of starting Phase II development in H126;

Note wording

'clinical...expertise in certain therapeutic areas' treatment, therapy, or drug - AVA6000/Dox???

;or geographies' so why do we no longer have an advisor represented in the US????

'Avacta is actively seeking a deal for AVA6000, ahead of starting Phase II development in H126' ..what has happened since end June 2025??? Would all these actions have taken place if a Partner seriously call the shorts...you need to do this you need to do that etc etc...deals don't just happen, they take a long time to sort out especially if big money is involved and a third party like Healthcare Royalty...